Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - fluorouracil, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - fluorouracil, quantity: 500 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - fluorouracil, quantity: 5 g - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - fluorouracil, quantity: 2.5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - fluorouracil, quantity: 500 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - fluorouracil, quantity: 5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - fluorouracil, quantity: 1000 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - fluorouracil, quantity: 2.5 g - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.